alfentanil has been researched along with Liver Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bower, S; Carter, RF; Roy, RC; Sear, JW | 1 |
| Brandom, BW; Cook, DR; Davis, JE; Davis, PJ; Scierka, AM; Stiller, RL | 1 |
2 other study(ies) available for alfentanil and Liver Diseases
| Article | Year |
|---|---|
Effects of different hepatic pathologies on disposition of alfentanil in anaesthetized patients.
Topics: Adult; Aged; Alfentanil; Anesthesia, General; Female; Humans; Liver; Liver Diseases; Liver Diseases, Alcoholic; Male; Metabolic Clearance Rate; Middle Aged; Orosomucoid; Protein Binding | 1992 |
Effects of cholestatic hepatic disease and chronic renal failure on alfentanil pharmacokinetics in children.
Topics: Adolescent; Alfentanil; Child; Child, Preschool; Cholestasis; Fentanyl; Humans; Infant; Kidney Failure, Chronic; Liver; Liver Diseases; Liver Transplantation | 1989 |